Publications by authors named "Till Lesk"
Article Synopsis
- The study aimed to assess the long-term effectiveness and safety of autologous hematopoietic stem cell transplantation (AHSCT) for severe autoimmune diseases in children and adolescents.
- Seven patients with various autoimmune conditions underwent AHSCT, showing a median progression-free survival of 4.2 years and overall survival rate of 100%, with most in clinical remission after a long follow-up.
- Despite some safety concerns, including infections and new autoimmune diseases, the results indicate that AHSCT can be a promising treatment for these challenging cases.
